66 results on '"Vallianou, Natalia G."'
Search Results
2. Sepsis-Associated Acute Kidney Injury: Where Are We Now?
3. The Interplay Between Dietary Choline and Cardiometabolic Disorders: A Review of Current Evidence
4. Alterations of the Adipo–Myokine Irisin in Sepsis and Septic Shock: Diagnostic and Prognostic Implications
5. Benign Recurrent Intrahepatic Cholestasis: Where Are We Now?
6. The Role of Endocrine Disruptors Bisphenols and Phthalates in Obesity: Current Evidence, Perspectives and Controversies
7. Obesity and Leukemia: Biological Mechanisms, Perspectives, and Challenges
8. Benign Recurrent Intrahepatic Cholestasis: Where are we now?
9. Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
10. Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights Into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
11. Immunotherapy in Head and Neck Cancer: Where Do We Stand?
12. Diagnostic and Prognostic Value of Serum Omentin-1 in Sepsis: A Prospective Study in Critically Ill Patients
13. The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future Perspectives
14. Obesity and Main Urologic Cancers: Current Systematic Evidence, Novel Biological Mechanisms, Perspectives and Challenges
15. The Role of the Respiratory Microbiome in the Pathogenesis of Aspiration Pneumonia: Implications for Diagnosis and Potential Therapeutic Choices
16. Lower circulating omentin-1 is independently linked to subclinical hypothyroidism reflecting cardiometabolic risk: an observational case-control and interventional, longitudinal study
17. Foods and Nutrients as Adjuvants in Cancer Chemo-prevention and Treatment
18. Could inhaled corticosteroids be the game changers in the prevention of severe COVID-19? A review of current evidence
19. SGLT-2 inhibitors in obesity and its associated cardiometabolic disorders: where do we stand?
20. Use of adenovirus type-5 vector vaccines in COVID-19: potential implications for metabolic health?
21. Therapeutic Potential of GLP-2 Analogs in Gastrointestinal Disorders: Current Knowledge, Nutritional Aspects, and Future Perspectives
22. Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges
23. Potential implications of lipid nanoparticles in the pathogenesis of myocarditis associated with the use of mRNA vaccines against SARS-CoV-2
24. Herpes zoster following COVID-19 vaccination in an immunocompetent and vaccinated for herpes zoster adult: A two-vaccine related event?
25. Corrigendum to: Multifaceted Secukinumab-induced Colitis
26. Multifaceted Secukinumab-induced Colitis
27. Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story
28. Cardiac MRI in Autoimmune Diseases: Where Are We Now?
29. Diabetes mellitus in the era of climate change
30. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management
31. Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem
32. Anti-viral treatment for SARS-CoV-2 infection: A race against time amidst the ongoing pandemic
33. Prediabetes screening: Questionable benefits in the golden years
34. Diabetes type 1: Can it be treated as an autoimmune disorder?
35. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
36. Co-existence of Follicular Lymphoma in the Lymph Node with High-grade B Cell Lymphoma in the Bone Marrow of a Patient with Spontaneous Tumor Lysis Syndrome
37. Unexpected finding
38. Clostridioides difficile infection in a patient with immunoglobulin A vasculitis: a triggering factor or a rare complication of the disease? A case-based review
39. An HHV-8 Positive HIV Negative Multicentric Castleman’s Disease, who Responded well to Rituximab Alone
40. Microbiome and hypertension
41. Fever and Leukemoid Reaction as the Presenting Manifestation of Disseminated Parotid Gland Carcinoma
42. Silimarin and Cancer
43. Metformin and gut microbiota: their interactions and their impact on diabetes
44. ANGPTL3 Inhibitors ― Their Role in Cardiovascular Disease Through Regulation of Lipid Metabolism ―
45. Microbiota and cancer: an update
46. Chronic Kidney Disease and Cardiovascular Disease: Is there Any Relationship?
47. Microbiome and diabetes: Where are we now?
48. Acute Myocarditis Due to Mushroom Ingestion
49. Diabetic hepatosclerosis: True clinical entity or ghost disease?
50. Inverse Relationship Between Adherenceto the Mediterranean Diet and Serum Cystatin C Levels
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.